Navigation Links
ViroPharma and Halozyme Therapeutics Announce Initiation of Phase 2 Evaluation of Subcutaneous Delivery of Cinryze® (C1 Esterase Inhibitor [Human]) with Hyaluronidase (rHuPH20)
Date:9/13/2011

EXTON, Pa., Sept. 13, 2011 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) and Halozyme Therapeutics (Nasdaq: HALO) announced today  that ViroPharma has initiated an open-label, multi-dose Phase 2 study to evaluate the safety, and pharmacokinetics and pharmacodynamics of subcutaneous administration of Cinryze® (C1 esterase inhibitor [human)] in combination with Halozyme's Enhanze™ technology, a proprietary drug delivery platform using Halozyme's recombinant human hyaluronidase enzyme (rHuPH20), in subjects with hereditary angioedema (HAE).  Initiation of the clinical trial has triggered a milestone payment of $3 million to Halozyme.

"Routine prophylaxis with intravenous Cinryze has transformed the management of HAE for many patients who also have the option for self administration. The initiation of this first phase 2 study with a novel, subcutaneous combination product represents an exciting new development for patients and their physicians and is an important milestone for ViroPharma," commented Jennifer Schranz, MD, ViroPharma's vice president, clinical research. "Our goal is to optimize the overall convenience of self-administration therapy with a single subcutaneous injection. This is an important part of our efforts to continually enhance the Cinryze experience for both existing and future patients by providing them an alternative administration option."

"The start of this Phase 2 subcutaneous trial in patients with HAE marks a great achievement for our partnership with ViroPharma, and I congratulate the team on this important accomplishment," said Gregory Frost, Ph.D., Halozyme's president and CEO. "Cinryze is the only HAE therapy approved for both routine prophylaxis against attacks along with self administration, and we expect this subcutaneous alterna
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ViroPharmas Buccolam® (Midazolam, Oromucosal Solution) Granted European Marketing Authorization for Treatment of Acute Seizures
2. ViroPharma to Participate in the Stifel Nicolaus 2011 Healthcare Conference
3. ViroPharma Announces Positive CHMP Opinion for Buccolam® (Midazolam, Oromucosal Solution) in the European Union
4. ViroPharmas Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE)
5. ViroPharma to Participate in the Jefferies 2011 Global Healthcare Conference
6. ViroPharma Launches Swell, an Original Documentary Chronicling the Lives of People Living with Hereditary Angioedema
7. ViroPharma Initiates Phase 2 Study of VP 20621 for Prevention of Recurrence of Clostridium difficile Infection (CDI)
8. Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human])
9. ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor
10. ViroPharma to Participate In Three May Healthcare Investor Conferences
11. ViroPharma to Release 2011 First Quarter Financial Results On April 28, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ... the Deutsche Bank Health Care Conference to be held ... Adrian Adams , Chief Executive Officer ... the Company and its product pipeline at 12:00 p.m. ... (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The presentation will ...
(Date:5/23/2013)... , May 24, 2013 3SBio Inc. ... "Company"), a leading China -based ... marketing biopharmaceutical products, announced today that, at an ... Company,s shareholders voted in favor of the proposal ... and plan of merger dated February 8, 2013, ...
(Date:5/23/2013)... 2013  Haemonetics Corporation (NYSE: HAE ) announced ... EVP-Business Development, will present at The Deutsche Bank 38 th ... MA on May 29, 2013 at 1:30pm Eastern ... The public may access Mr. Lindop,s presentation live via ... Haemonetics (NYSE: HAE ) is a ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 43SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3
(Date:5/25/2013)... Angeles, California (PRWEB) May 25, 2013 According ... Magazine titled “Hooked on a Feeling,” nearly 30 million Americans ... beach to tan despite knowing the health risks. ... relaxing, seductive and even addictive effect on the brains of ... data included in the article so I can’t say that ...
(Date:5/25/2013)... Dr. Leslie Gerstman announced today that ... on the neck, on the brow and under the chin ... Ultherapy is a non-surgical procedure for the face and neck ... the skin over time. The use of FDA-cleared ultrasound technology ... treat the deepest support layers of the skin – typically ...
(Date:5/25/2013)... May 25, 2013 A disorder of ... of peripheral neuropathy. According to neuropathy expert doctor Helen ... is estimated that the disorder affects almost 50% of ... arising from Diabetes. The high blood sugar levels in ... patients suffering from it usually tend to have abnormally ...
(Date:5/25/2013)... The report “Global Food Encapsulation Market ... Ingredients, Shell Materials, Packaging, & Geography: Trends & ... market with analysis and forecasting of the global ... driving and restraining factors for the global food ... challenges. The market is segmented and revenue are ...
(Date:5/25/2013)... 2013 Absolute Surgical Specialists, serving Sun City ... NALA’s businesses throughout the country participating in Shop Local for ... the nationwide event as he understands what military families go ... Army. He said, “I wanted to give something back, as ... I live here too.” , Shop Local for a Cause ...
Breaking Medicine News(10 mins):Health News:Sun Damage – Are UV Rays Addictive? 2Health News:Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure – Ultherapy – in NYC and NJ 2Health News:Diabetic Neuropathy treatment hits new grounds- Neuracel launches the complete natural treatment 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 3Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2
... Smoking in public places and places of work is now ... ever-expanding club of nations that bar the habit. ... offices and other enclosed or partially enclosed places of work, ... ,Individuals will, however, still be able to light ...
... to banish trans fats from its restaurants, but the city ... to display calorie information on their menus. ,For ... healthier cooking oils seems to have gone smoothly, although some ... heart of the fashionable Soho district, "Jerry's" diner abandoned trans ...
... capitalism is bad for men's health, according to a recent ... collapse of the Soviet Union. ,The life ... six years between 1991 and 1994 amid social disruption, physical ... men were affected depended upon how rough the transition to ...
... germ cell tumour patients treated with platinum-based chemotherapy ... function and reproductive ability. ,The ... also found that despite having reproductive and sexual ... counterparts to be involved in meaningful, positive relationships. ...
... out from her Sierra Towers apartment to lead a booze free ... at a very happening place, so the 'party girl' who is ... to go back there once she completes her therapy. ... a source, as saying. ,"Lindsay has made the ...
... rampant industrial pollution, China has unveiled a conservation strategy ... farmland to forests. ,China is home ... and half of those unique to China, about 5000 ... ,According to Jia Jiansheng of the department of wildlife ...
Cached Medicine News:Health News:Public Places in England Go Smoke Free 2Health News:New York Bans Trans Fats in Restaurants 2Health News:New York Bans Trans Fats in Restaurants 3Health News:Capitalism is Bad for Men's Health: Study 2Health News:Survivors of Rare Ovarian Cancer may Retain Menstrual Function and Reproductive Ability 2Health News:Survivors of Rare Ovarian Cancer may Retain Menstrual Function and Reproductive Ability 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: